ReszkaAA, Halasy-NagyJ, RodanGA. Nitrogen-bisphosphonates block retinoblastoma phosphorylation and cell growth by inhibiting the cholesterol biosynthetic pathway in a keratinocyte model for esophageal irritation. Mol Pharmacol., 2001; 59:193–202.
2.
AlcarazM, OlivaresA, ArmeroD, Alcaraz-SauraM, AchelD. Zoledronic acid and radiation: toxicity, synergy or radiosensitization?. Clin Transl Oncol., 2013; 15:300–306.
3.
ZhangJX, DangSC, YinK, JiangDL. Protective effect of clodronate-containing liposomes on intestinal mucosal injury in rats with severe acute pancreatitis. Hepatobiliary Pancreat Dis Int., 2011; 10:544–551.
4.
ParkinsonT, PrydeDC. Small molecule drug discovery for Dengue and West Nile viruses: applying experience from hepatitis C virus. Future Med Chem., 2010; 2:1181–1203.
5.
DoanDN, LiKQ, BasavannacharyaC, VasudevanSG, MadhusudhanMS. Transplantation of a hydrogen bonding network from West Nile virus protease onto Dengue-2 protease improves catalytic efficiency and sheds light on substrate specificity. Protein Eng Des Sel., 2012; 25:843–850.
6.
Cregar-HernandezL, JiaoGS, JohnsonAT, LehrerAT, WongTA, MargosiakSA. Small molecule pan-dengue and West Nile virus NS3 protease inhibitors. Antivir Chem Chemother., 2011; 21:209–217.
7.
HamaueN, OgataA, TeradoM, et al.Entacapone, a catechol-O-methyltransferase inhibitor, improves the motor activity and dopamine content of basal ganglia in a rat model of Parkinson's disease induced by Japanese encephalitis virus. Brain Res., 2010; 1309:110–115.
8.
NitscheC, SteuerC, KleinCD. Arylcyanoacrylamides as inhibitors of the Dengue and West Nile virus proteases. Bioorg Med Chem., 2011; 19:7318–7337.
9.
BensonSC, PershadsinghHA, HoCI, et al.Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity. Hypertension., 2004; 43:993–1002.
YuanX, ZhuD, GuoXL, et al.Telmisartan attenuates myocardial apoptosis induced by chronic intermittent hypoxia in rats: modulation of nitric oxide metabolism and inflammatory mediators. Sleep Breath, 2014Nov21. [Epub ahead of print]
ZhouJ, ZhangW, LiangB, et al.PPARgamma activation induces autophagy in breast cancer cells. Int J Biochem Cell Biol., 2009; 41:2334–2342.
14.
LiBH, LiaoSQ, YinYW, et al.Telmisartan-induced PPARγ activity attenuates lipid accumulation in VSMCs via induction of autophagy. Mol Biol Rep., 2014Sep24. [Epub ahead of print]
15.
TancevskiI, DemetzE, EllerP. Sobetirome: a selective thyromimetic for the treatment of dyslipidemia. Recent Pat Cardiovasc Drug Discov., 2011; 6:16–19.
16.
ScanlanTS. Sobetirome: a case history of bench-to-clinic drug discovery and development. Heart Fail Rev., 2010; 15:177–182.
17.
KempS, WandersRJ. X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism, ABC half-transporters and the complicated route to treatment. Mol Genet Metab., 2007; 90:268–276.
18.
GeninEC, GeillonF, GondcailleC, et al.Substrate specificity overlap and interaction between adrenoleukodystrophy protein (ALDP/ABCD1) and adrenoleukodystrophy-related protein (ALDRP/ABCD2). J Biol Chem., 2011; 286:8075–8084.
19.
GeninEC, GondcailleC, TrompierD, SavaryS. Induction of the adrenoleukodystrophy-related gene (ABCD2) by thyromimetics. J Steroid Biochem Mol Biol., 2009; 116:37–43.
20.
DrayA. Mechanism of action of capsaicin-like molecules on sensory neurons. Life Sci., 1992; 51:1759–1765.
21.
EbiharaT, TakahashiH, EbiharaS, et al.Capsaicin troche for swallowing dysfunction in older people. J Am Geriatr Soc., 2005; 53:824–828.
22.
EbiharaS, KohzukiM, SumiY, EbiharaT. Sensory stimulation to improve swallowing reflex and prevent aspiration pneumonia in elderly dysphagic people. J Pharmacol Sci., 2011; 115:99–104.
23.
RofesL, ArreolaV, MartinA, ClavéP. Natural capsaicinoids improve swallow response in older patients with oropharyngeal dysphagia. Gut., 2013; 62:1280–1287.
24.
TekdemirI, AslanA, ElhanA. A clinico-anatomic study of the auricular branch of the vagus nerve and Arnold's ear-cough reflex. Surg Radiol Anat., 1998; 20:253–257.
25.
KondoE, JinnouchiO, OhnishiH, et al.Effects of aural stimulation with capsaicin ointment on swallowing function in elderly patients with non-obstructive dysphagia. Clin Interv Aging., 2014; 9:1661–1667.
26.
Corrêa-LimaAR, Miranda-FilhoDD, ValençaMM, Andrade-ValençaL. Risk factors for acute symptomatic seizure in bacterial meningitis in children. J Child Neurol., 2014Nov10. [Epub ahead of print]
27.
LiuGJ, MiddletonRJ, HattyCR, et al.The 18 kDa translocator protein, microglia and neuroinflammation. Brain Pathol., 2014; 24:631–653.
28.
BarichelloT, CollodelA, GenerosoJS, et al.Targets for adjunctive therapy in pneumococcal meningitis. J Neuroimmunol., 2014. [Epub ahead of print]
29.
GarbeTR. Co-induction of methyltransferase Rv0560c by naphthoquinones and fibric acids suggests attenuation of isoprenoid quinone action in Mycobacterium tuberculosis. Can J Microbiol., 2004; 50:771–778.
30.
Reich-SlotkyR, KabbashCA, Della-LattaP, et al.Gemfibrozil inhibits Legionella pneumophila and Mycobacterium tuberculosis enoyl coenzyme A reductases and blocks intracellular growth of these bacteria in macrophages. J Bacteriol., 2009; 191:5262–5271.
31.
MieselL, RozwarskiDA, SacchettiniJC, JacobsWRJr. Mechanisms for isoniazid action and resistance. Novartis Found Symp., 1998; 217:209–220.
32.
CruikshankSJ, HopperstadM, YoungerM, ConnorsBW, SprayDC, SrinivasM. Potent block of Cx36 and Cx50 gap junction channels by mefloquine. Proc Natl Acad Sci USA., 2004; 101:12364–12369.
33.
YoonSY, RobinsonCR, ZhangH, DoughertyPM. Spinal astrocyte gap junctions contribute to oxaliplatin-induced mechanical hypersensitivity. J Pain., 2013; 14:205–214.
34.
Rendi-WagnerP, NoedlH, WernsdorferWH, WiedermannG, MikolasekA, KollaritschH. Unexpected frequency, duration and spectrum of adverse events after therapeutic dose of mefloquine in healthy adults. Acta Trop., 2002; 81:167–173.
35.
XiaoSH. Mefloquine, a new type of compound against schistosomes and other helminthes in experimental studies. Parasitol Res., 2013; 112:3723–3740.
36.
SchindlerU, StrobelH, SchönafingerK, et al.Biochemistry and pharmacology of novel anthranilic acid derivatives activating heme-oxidized soluble guanylyl cyclase. Mol Pharmacol., 2006; 69:1260–1268.
37.
CerriC, CanalN, FrattolaL. Guanylate cyclase activity in normal and diseased human muscle. J Neurol Neurosurg Psychiatry., 1978; 41:805–808.
38.
DaiB, LiuY, MeiC, et al.Rosiglitazone attenuates development of polycystic kidney disease and prolongs survival in Han:SPRD rats. Clin Sci (Lond)., 2010; 119:323–333.
39.
YoshiharaD, KurahashiH, MoritaM, et al.PPAR-gamma agonist ameliorates kidney and liver disease in an orthologous rat model of human autosomal recessive polycystic kidney disease. Am J Physiol Renal Physiol., 2011; 300:F465–F474.
40.
VerkmanAS, LukacsGL, GaliettaLJ. CFTR chloride channel drug discovery—inhibitors as antidiarrheals and activators for therapy of cystic fibrosis. Curr Pharm Des., 2006; 12:2235–2247.
41.
BoomsmaF, van den MeirackerA, Man in't VeldA, SchalekampM. Contrasting effects of peripheral decarboxylase inhibitors on plasma activity of aromatic-L-amino acid decarboxylase and semicarbazide-sensitive amine oxidase in Parkinson's disease. Life Sci., 1995; 57:1753–1759.
42.
WestonCJ, ShepherdEL, ClaridgeLC, et al.Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosis. J Clin Invest., 2014. pii: 73722. [Epub ahead of print]
43.
OlivéM, UnzetaM, MorenoD, FerrerI. Overexpression of semicarbazide-sensitive amine oxidase in human myopathies. Muscle Nerve., 2004; 29:261–266.
44.
Carre-PierratM, LafouxA, TanniouG, et al.Pre-clinical study of 21 approved drugs in the mdx mouse. Neuromuscul Disord., 2011; 21:313–327.
